BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$9.09B
1-Year Return
13.74%
This Quarter Return
+5.58%
1 Year Return
+13.74%
3 Year Return
+18.18%
5 Year Return
–
10 Year Return
–
AUM
$4.04B
AUM Growth
+$1.97B
(+95%)
Cap. Flow
+$1.87B
Cap. Flow
% of AUM
46.25%
Top 10 Holdings %
Top 10 Hldgs %
52.73%
Holding
1,492
New
421
Increased
286
Reduced
244
Closed
504
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$1.39B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$266M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$151M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$94.2M |
| 5 |
SUPV
Grupo Supervielle
SUPV
|
+$16.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$80.9M |
| 2 |
Microsoft
MSFT
|
+$55.2M |
| 3 |
Spotify
SPOT
|
+$34.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$23.2M |
| 5 |
Comcast
CMCSA
|
+$16.8M |
Sector Composition
| 1 | Financials | 8.39% |
| 2 | Technology | 8.05% |
| 3 | Healthcare | 6.05% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Verra Mobility
VRRM
$3.96B
| $271K | ﹤0.01% |
11,216
-12,270
| -52% | -$297K |
|
777
Recursion Pharmaceuticals
RXRX
$2.13B
| $271K | ﹤0.01% |
+40,091
| New | +$271K |
|
778
Ubiquiti
UI
$37.4B
| $271K | ﹤0.01% |
816
-965
| -54% | -$320K |
|
779
ACV Auctions
ACVA
$1.78B
| $270K | ﹤0.01% |
+12,491
| New | +$270K |
|
780
Catalyst Pharmaceutical
CPRX
$2.47B
| $267K | ﹤0.01% |
12,817
-7,252
| -36% | -$151K |
|
781
Vishay Intertechnology
VSH
$2.09B
| $267K | ﹤0.01% |
+15,734
| New | +$267K |
|
782
Tilray
TLRY
$1.15B
| $266K | ﹤0.01% |
+200,000
| New | +$266K |
|
783
NCR Voyix
VYX
$1.79B
| $266K | ﹤0.01% |
+19,195
| New | +$266K |
|
784
Alamo Group
ALG
$2.54B
| $265K | ﹤0.01% |
1,427
-137
| -9% | -$25.5K |
|
785
Apogee Enterprises
APOG
$925M
| $263K | ﹤0.01% |
3,683
+514
| +16% | +$36.7K |
|
786
DexCom
DXCM
$30B
| $261K | ﹤0.01% |
+3,350
| New | +$261K |
|
787
Steelcase
SCS
$1.94B
| $260K | ﹤0.01% |
+22,012
| New | +$260K |
|
788
Genworth Financial
GNW
$3.58B
| $260K | ﹤0.01% |
+37,205
| New | +$260K |
|
789
Plexus
PLXS
$3.77B
| $260K | ﹤0.01% |
1,659
-1,323
| -44% | -$207K |
|
790
Rambus
RMBS
$9.47B
| $259K | ﹤0.01% |
4,907
-62,201
| -93% | -$3.29M |
|
791
UFP Industries
UFPI
$5.97B
| $258K | ﹤0.01% |
2,294
-6,259
| -73% | -$705K |
|
792
Viridian Therapeutics
VRDN
$1.6B
| $258K | ﹤0.01% |
+13,473
| New | +$258K |
|
793
Olo Inc
OLO
$1.74B
| $257K | ﹤0.01% |
33,444
+10,442
| +45% | +$80.2K |
|
|
HPP
794
Hudson Pacific Properties
HPP
$1.11B
| $257K | ﹤0.01% |
84,671
+66,821
| +374% | +$202K |
|
795
Amphastar Pharmaceuticals
AMPH
$1.34B
| $256K | ﹤0.01% |
+6,905
| New | +$256K |
|
796
ImmunityBio
IBRX
$2.44B
| $255K | ﹤0.01% |
+99,757
| New | +$255K |
|
797
Huron Consulting
HURN
$2.44B
| $255K | ﹤0.01% |
+2,055
| New | +$255K |
|
798
Under Armour
UAA
$2.15B
| $254K | ﹤0.01% |
+30,652
| New | +$254K |
|
799
Penumbra
PEN
$10.8B
| $253K | ﹤0.01% |
+1,067
| New | +$253K |
|
800
Keysight
KEYS
$29.6B
| $253K | ﹤0.01% |
1,577
-6,529
| -81% | -$1.05M |
|